From the cherry tomatoes on your grocery list to the automated on-board driver assistant system ‘MobileEye’ in your car, and the FDA Approved treatment medications; for ovarian cancer ‘Doxil’, chemotherapy ‘Erbitux’, and Alzheimer’s disease ‘Exelon’, Yissum’s world renowned inventions have been making an impact on human lives across the world much longer than we realize. Since 1964 Yissum, the research development company of the Hebrew University of Jerusalem (HIJU) not only has helped its researchers to start more than 110 spin-off companies, of which some are currently valued over $10b on the stock exchange, but also facilitated the registration of 9,300 patents that cover more than 2,600 inventions, and licensed 880 innovations. Not surprisingly, this exceptional track record has attracted the attention of a number of industry giants, including Intel, Google, Philips, Coca Cola, Roche, GM, and P&G, for the establishment of long term research collaborations.
Want to learn more about the story behind Yissum’s breakthrough technologies? Read the detailed case study at: http://ub-cooperation.eu/index/casestudies